Product Information
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1919 per EA under NDC 68462057801. Its NADAC has been published 134 times since Jan 31, 2024.
FDA first approved this application on Feb 11, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
Benazepril Hydrochloride and HydrochlorothiazideStrength
20; 12.5 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462057801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076631FDA Approved
2/11/2004
TE Code
AB
On Market Since
2/11/2004
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 134 times since Jan 31, 2024, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1919 per EA |
|---|---|
| All-time high | $0.4689 (Apr 10, 2024) |
| All-time low | $0.1503 (Nov 20, 2024) |
| 52-week high | $0.2705 |
| 52-week low | $0.1742 |
| Median price | $0.2349 |
| Average price | $0.2399 |
| Largest weekly change | +42.7% (Aug 21, 2024) |
| Weeks tracked | 134 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1919 per EA (NDC 68462057801), effective Aug 19, 2026.
How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 50.0%. It has been tracked across 134 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Jan 31, 2024, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1503 (Nov 20, 2024) to a high of $0.4689 (Apr 10, 2024), with a median of $0.2349 per EA.
Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 68462057801) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.